Aberrant transcriptional activation via H3K79 methylation by DOT1L has been implicated in the development of leukemias that derive from oncogenic chromosomal rearrangements of the MLL (mixed lineage leukemia) gene. The gene discussed is DOT1L; the disease is leukemia.